Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) shares surged 24.44 percent to close at $6.16 a share Wednesday. The stock traded between $5.95 and $6.83 on volume of 44.82 million shares traded. The company announced that the FDA has the granted accelerated approval of NORTHERA for the treatment of symptomatic neurogenic orthostatic hypotension. Shares of Chelsea Therapeutics are up approximately 40.0 percent year-to-date.
Get more information on Chelsea Therapeutics and free access to the in-depth equity report at:
www.FiveStarEquities.com/CHTP
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) shares surged 34.65 percent to close at $11.89 a share Wednesday. The stock traded between $8.88 and $12.13 on volume 1.86 million shares traded. The company announced an exclusive distribution right renewal with Timesco related to the CLX laryngoscope products. Shares of Dehaier Medical Systems are up over 200.0 percent year-to-date.
Get more information on Dehaier Medical Systems and free access to the in-depth equity report at:
www.FiveStarEquities.com/DHRM
NanoViricides Inc. (NYSEMKT: NNVC) shares jumped 16.62 percent to close at $4.00 a share Wednesday. The stock traded between $3.41 and $4.04 on volume of 1.43 million shares traded. The company announced that it has an estimated $38M of current assets plus restricted cash in hand. Shares of NanoViricides are down approximately 16.0 percent year-to-date.
Get more information on NanoViricides and free access to the in-depth equity report at:
www.FiveStarEquities.com/NNVC
Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) shares spiked 20.63 percent to close at $3.80 a share Wednesday. The stock traded between $3.52 and $4.35 on volume 4.04 million shares traded. The company announced that it has received approval for its new Microcyn60 Oral Care family of products in Mexico. Shares of Oculus are up approximately 10.0 percent year-to-date.
Get more information on Oculus free access to the in-depth equity report at:
www.FiveStarEquities.com/OCLS
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Five Star Equities
[email protected]